NCI-60 Human Tumor Cell Lines Screen
 |
|
| Agency overview | |
|---|---|
| Formed | 1937 |
| Jurisdiction | United States |
| Headquarters | Rockville, Maryland U.S. |
| Agency executive |
|
| Parent agency |
U.S. Department of Health and Human Services National Institutes of Health |
| Website | www.cancer.gov |
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI coordinates the U.S. National Cancer Program and conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
On June 10, 2017, President Donald J. Trump announced his intent to appoint Norman Sharpless as director of the National Cancer Institute.
NCI is the oldest and has the largest budget and research program of the 27 institutes and centers of the NIH. It fulfills the majority of its mission via an extramural program that provides grants for cancer research. Additionally, the National Cancer Institute has intramural research programs in Bethesda, Maryland and at the Frederick National Laboratory for Cancer Research at Fort Detrick, in Frederick, Maryland. The NCI receives more than $5 billion in funding each year.
The NCI supports a nationwide network of 69 NCI-designated Cancer Centers with a dedicated focus on cancer research and treatment and maintains the National Clinical Trials Network.
The NCI played an early role in the discovery of anti-cancer drugs in the U.S. According to a 1996 NCI analysis of drugs approved by the Food and Drug Administration (FDA), two-thirds of the anti-cancer drugs approved as of the end of 1995 were NCI-sponsored Investigational New Drugs:
...
Wikipedia